14456.00GBp-0.56%Mkt Cap: 243.69B $P/E: 28.741d ago
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza,…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Pricier
P/B
Avg
Div Yield
Higher
1M Perf
Avg
$1.08TUSDP/E 43.1
$633.19BUSDP/E 30.5
$461.26BUSDP/E 128.0
$314.36BUSDP/E 21.6
$319.99BUSDP/E 36.5
$284.58BUSDP/E 22.8
$278.57BUSDP/E 22.6
$210.73BUSDP/E 11.9
$201.93BUSDP/E 26.0
$162.98BUSDP/E 17.9
$138.61BUSDP/E 18.6
$118.71BUSDP/E 16.3
$98.63BUSDP/E 19.1
$87.73BUSDP/E 14.2
$56.98BUSD
$31.91BUSDP/E 23.3
MRV
Marvell Technology, Inc.$26.62BUSDP/E 10.1
$11.36BUSDP/E 22.8
$11.03BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.72BUSDP/E 14.9
$3.56BUSDP/E 14.6
$3.02BUSDP/E 18.4
$54.93MUSD
$39.70MUSD
ELXR
Elixxer Ltd.$9.51MUSD
ROSE
DocMorris AG—
CELG-RI
Bristol-Myers Squibb Company Ce—
FLXN
Horizon Flexible Income ETF—P/E 27.2
Indicators:|
Key Statistics
Company
Market Cap243.69B $
Enterprise Value266.10B $
Revenue (TTM)65.69B $
Gross Profit52.29B $
Net Income (TTM)11.11B $
Revenue/Share42.39 USD
Last Price14456.00 GBp
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees96.1K
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - General
ISINGB0009895292
Valuation
P/E (Trailing)28.74
P/E (Forward)16.15
PEG1.41
EV/EBITDA12.22
EV/Revenue4.05
P/S3.62
P/B6.08
EPS (TTM)5.03
EPS (Forward)8.73
52W Range
0.000091% of range15830.00
52W High15830.00 GBp
52W Low0.0000 GBp
Profitability
Gross Margin81.90%
Oper. Margin27.94%
EBITDA Margin33.13%
Profit Margin17.41%
ROE21.01%
ROA8.96%
Growth
Revenue Growth12.50%
Earnings Growth5.30%
Cash Flow & Leverage
Operating CF15.84B $
CapEx (TTM)6.42B $
FCF Margin10.85%
FCF Yield2.93%
Net Debt28.65B $
Net Debt/EBITDA1.32
Balance Sheet
Debt/Equity0.60
Current Ratio0.91
Quick Ratio0.70
Book Value/Sh23.17 GBp
Cash/Share4.955 GBp
Dividends
Fwd Div Rate2.360 GBp
Trail. Div Rate3.200 GBp
Div. Yield1.65%
5Y Avg Yield2.09%
Payout Ratio47.70%
Ex-Div DateFeb 19, 2026
Pay Date—
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)16668.04 GBp
Upside (mean)+15.3%
Target Range11477.01 GBp – 19022.31 GBp
GBp11477.01+15.3% to meanGBp19022.31
# Analysts21
Ownership
Shares Out.1.55B
Float1.54B
Insiders0.05%
Institutions67.96%
Technical
SMA 5013718.92 (+5.4%)
SMA 20013754.32 (+5.1%)
Beta0.21
S&P 52W Chg20.05%
Avg Vol (30d)1.87M
Avg Vol (10d)2.58M
Technical Indicators
RSI (14)61.4
MACD153.3112
MACD Signal27.8332
MACD Hist.+125.4780
BB Upper14552.14 GBp
BB Middle13712.60 GBp
BB Lower12873.06 GBp
BB Width12.24%
ATR (14)750.42 GBp
Vol Ratio (20d)0.35x